ID
37674
Descripción
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form is to be filled with data regarding pharmacodynamic results relating to the coagulation system and lung epithelial cell injury, taken repeatedly on Day 1 and 3, and can also be used for repeat analyses.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Palabras clave
Versiones (2)
- 13/8/19 13/8/19 -
- 15/8/19 15/8/19 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
15 de agosto de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
SB-681323 in ALI/ARDS risk patients - NCT00996840
Pharmacodynamics Results
- StudyEvent: ODM
Descripción
Pharmacodynamics Results
Alias
- UMLS CUI-1
- C0851347
- UMLS CUI-2
- C1254595
Descripción
[read-only]
Tipo de datos
datetime
Alias
- UMLS CUI [1,1]
- C3897500
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0178602
Descripción
Sample date/time
Tipo de datos
datetime
Alias
- UMLS CUI [1,1]
- C0200345
- UMLS CUI [1,2]
- C1264639
- UMLS CUI [1,3]
- C0031328
Descripción
INR Result Type
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0525032
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C0332307
Descripción
if applicable
Tipo de datos
float
Alias
- UMLS CUI [1,1]
- C2347373
- UMLS CUI [1,2]
- C0525032
Descripción
if applicable
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C2350015
- UMLS CUI [1,3]
- C0525032
Descripción
PT Result Type
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C0332307
- UMLS CUI [1,3]
- C0491338
Descripción
if applicable
Tipo de datos
float
Alias
- UMLS CUI [1,1]
- C2347373
- UMLS CUI [1,2]
- C0491338
Descripción
if applicable
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C2350015
- UMLS CUI [1,3]
- C0491338
Descripción
PTT Result Type
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0030605
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C0332307
Descripción
if applicable
Tipo de datos
float
Alias
- UMLS CUI [1,1]
- C2347373
- UMLS CUI [1,2]
- C0030605
Descripción
if applicable
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C2350015
- UMLS CUI [1,3]
- C0030605
Similar models
Pharmacodynamics Results
- StudyEvent: ODM
C1254595 (UMLS CUI-2)
C0304229 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C1264639 (UMLS CUI [1,2])
C0031328 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C0525032 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,2])
C0525032 (UMLS CUI [1,3])
C0332307 (UMLS CUI [1,2])
C0491338 (UMLS CUI [1,3])
C0491338 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,2])
C0491338 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C0030605 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,2])
C0030605 (UMLS CUI [1,3])
Sin comentarios